Literature DB >> 1958215

Thermostabilization of recombinant human and bovine CuZn superoxide dismutases by replacement of free cysteines.

R A Hallewell1, K C Imlay, P Lee, N M Fong, C Gallegos, E D Getzoff, J A Tainer, D E Cabelli, P Tekamp-Olson, G T Mullenbach.   

Abstract

Human CuZn superoxide dismutase (HSOD) has two free cysteines: a buried cysteine (Cys6) located in a beta-strand, and a solvent accessible cysteine (Cys111) located in a loop region. The highly homologous bovine enzyme (BSOD) has a single buried Cys6 residue. Cys6 residues in HSOD and BSOD were replaced by alanine and Cys111 residues in HSOD by serine. The mutant enzymes were expressed and purified from yeast and had normal specific activities. The relative resistance of the purified proteins to irreversible inactivation of enzymatic activity by heating at 70 degrees C was HSOD Ala6 Ser111 greater than BSOD Ala6 Ser109 greater than BSOD Cys6 Ser109 (wild type) greater than HSOD Ala6 Cys111 greater than HSOD Cys6 Ser111 greater than HSOD Cys111 (wild type). In all cases, removal of a free cysteine residue increased thermostability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958215     DOI: 10.1016/s0006-291x(05)81443-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties.

Authors:  Mitchel D de Beus; Jinhyuk Chung; Wilfredo Colón
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

Review 2.  Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.

Authors:  J J P Perry; L Fan; J A Tainer
Journal:  Neuroscience       Date:  2006-12-15       Impact factor: 3.590

Review 3.  The structural biochemistry of the superoxide dismutases.

Authors:  J J P Perry; D S Shin; E D Getzoff; J A Tainer
Journal:  Biochim Biophys Acta       Date:  2009-11-13

4.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes.

Authors:  Ashley J Pratt; David S Shin; Gregory E Merz; Robert P Rambo; W Andrew Lancaster; Kevin N Dyer; Peter P Borbat; Farris L Poole; Michael W W Adams; Jack H Freed; Brian R Crane; John A Tainer; Elizabeth D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

5.  Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species.

Authors:  Can Kayatekin; Jill A Zitzewitz; C Robert Matthews
Journal:  J Mol Biol       Date:  2010-02-23       Impact factor: 5.469

6.  Enthalpic barriers dominate the folding and unfolding of the human Cu, Zn superoxide dismutase monomer.

Authors:  Can Kayatekin; Noah R Cohen; C Robert Matthews
Journal:  J Mol Biol       Date:  2012-09-18       Impact factor: 5.469

7.  Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species.

Authors:  Anna-Karin E Svensson; Osman Bilsel; Can Kayatekin; Jessica A Adefusika; Jill A Zitzewitz; C Robert Matthews
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

Review 8.  The role of thiols and disulfides on protein stability.

Authors:  Maulik V Trivedi; Jennifer S Laurence; Teruna J Siahaan
Journal:  Curr Protein Pept Sci       Date:  2009-12       Impact factor: 3.272

9.  Characterization of fish Cu/Zn-superoxide dismutase and its protection from oxidative stress.

Authors:  Chuian-Fu Ken; Chi-Tsai Lin; Jei-Fu Shaw; Jen-Leih Wu
Journal:  Mar Biotechnol (NY)       Date:  2003 Mar-Apr       Impact factor: 3.619

10.  Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase.

Authors:  Zeynep A Oztug Durer; Jeffrey A Cohlberg; Phong Dinh; Shelby Padua; Krista Ehrenclou; Sean Downes; James K Tan; Yoko Nakano; Christopher J Bowman; Jessica L Hoskins; Chuhee Kwon; Andrew Z Mason; Jorge A Rodriguez; Peter A Doucette; Bryan F Shaw; Joan Selverstone Valentine
Journal:  PLoS One       Date:  2009-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.